Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boehringer ingelheim
5
×
deals
5
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
san francisco blog main
biotech
boston
eli lilly
hepatitis b
san francisco top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
biontech
clinical trials
indiana blog main
indiana top stories
new york blog main
new york top stories
rna interference
san diego blog main
san diego top stories
startups
3m ventures
abbvie
allergan aesthetics
alnylam pharmaceutials
alnylam pharmaceuticals
alzheimer's disease
amgen
apps
aptar pharma
arrowhead pharmaceuticals
asthma
asthmapolis
astrazeneca
athira pharma
What
deal
medicines
bio
companies
dicerna
drug
latest
pharma
rna
abandoning
acquire
acquisition
acquisitions
ago
baggage
bets
biggest
boosts
build
buy
cancer
caught
causing
ceo
comes
company’s
connected
cut
cuts
daniel
date
debut
development
devices
disease
dyne’s
effective
endorsement
enticed
evidence
Language
unset
Current search:
" boehringer ingelheim "
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
